Last reviewed · How we verify
two measles attenuated live vaccine — Competitive Intelligence Brief
marketed
Biologic
Live · refreshed every 30 min
Target snapshot
two measles attenuated live vaccine (two measles attenuated live vaccine) — Chinese Academy of Medical Sciences.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| two measles attenuated live vaccine TARGET | two measles attenuated live vaccine | Chinese Academy of Medical Sciences | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- two measles attenuated live vaccine CI watch — RSS
- two measles attenuated live vaccine CI watch — Atom
- two measles attenuated live vaccine CI watch — JSON
- two measles attenuated live vaccine alone — RSS
Cite this brief
Drug Landscape (2026). two measles attenuated live vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/two-measles-attenuated-live-vaccine. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab